FDA Inspection 934502 — Regenerative Biologics, Inc.

Regenerative Biologics, Inc. — FEI 3003567064

The FDA completed an inspection of Regenerative Biologics, Inc. on July 10, 2015 in Tallahassee, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 10, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tallahassee, FL (United States)